Browse by promiscous Epitopes having more than one one strain/HLA - class binding affinity in VLCvirus

The following table provides information on identifed promiscous epitopes against all nine major oncogenic lung cancer causing virus species. The count of all the predicted promiscous epitopes is given in the table i.e. MHC binder, T cell epitope, B cell epitope or adjuvant. These promiscous epitope have the capability to bind different class of MHC molecules as well as having strong vaccine inducing potential. This will make them as an attractive vaccine candidate, as they can cover large human popopulation. We have identified promiscous epitopes against all the virus reference proteome used in VLCvirus study. Moreover, we have categorize the promiscous epitopes in different category as provided in the table. The advantage of this categorization can be seen in terms that - if user wants to identify promiscous epitopes that shows affinity with multiple HLA- class as well as should possess B-cell, T-cell and Vaccine adjuvant potential. Then by going through the table, all the user query can be obtained in just a single click.

Epitope properties No of records showing that particular properties
Epitopes identified having all Ninemer57059
Promiscuos epitopes having T-cell, B-cell and MHC -I, II binder422
Promiscuous epitopes having T-cell, B-cell and MHC -I binder3074
Promiscuos epitopes having T-cell, B-cell and MHC -II binder543
Promiscuos epitopes having B-cell, Vaccine adjuvant and MHC -I, II binder74
Promiscuos epitopes having B-cell, Vaccine adjuvant and MHC -I binder321
Promiscuos epitopes having B-cell, Vaccine adjuvant and MHC -II binder99
Promiscous Epitopes having T-cell inducing potential17057
Promiscous Epitopes having B-cell inducing potential6507
Promiscous Epitopes having MHC - I, II binding potential6719
Promiscous Epitopes having T-cell and MHC - I, II binding potential1958
Promiscous Epitopes having T-cell and MHC - I binding potential12202
Promiscous Epitopes having T-cell and MHC - II binding potential2001
Promiscous Epitopes having T-cell, B-cell, Vaccine Adjuvant and MHC - I, II binding potential25
Promiscous Epitopes having T-cell, B-cell, Vaccine Adjuvant and MHC - I binding potential140
Promiscous Epitopes having T-cell, B-cell, Vaccine Adjuvant and MHC - II binding potential26
Promiscous Epitopes having T-cell, B-cell and Vaccine Adjuvant potential 146
Promiscous Epitopes having T-cell, Vaccine Adjuvant and MHC - I, II potential 468
Promiscous Epitopes having T-cell, Vaccine Adjuvant and MHC - I potential 1963
Promiscous Epitopes having T-cell, Vaccine Adjuvant and MHC - II potential 482
Promiscous Epitopes having Vaccine Adjuvant property 8452